B* Phenotypes | Frequency in CVID and IgGSD Index Patients (n = 240) | Frequency in Control Subjects (n) | Significant Uncorrected Values of p | Significant Corrected Values of p 2 |
---|---|---|---|---|
07 | 0.2667 | 0.2259 (1,321) | Â | Â |
08 | 0.2583 | 0.2487 (1,315) | Â | Â |
13 | 0.0250 | 0.0343 (1,314) | Â | Â |
14 | 0.1167 | 0.0639 (1,314) | 0.0037 | Â |
15 | 0.0792 | 0.0144 (1,320) | < 0.0001 | < 0.0030 |
18 | 0.0708 | 0.0775 (1,251) | Â | Â |
27 | 0.0708 | 0.0895 (1,318) | Â | Â |
35 | 0.0917 | 0.1406 (1,309) | 0.0403 | Â |
37 | 0.0250 | 0.0240 (1,167) | Â | Â |
38 | 0.0167 | 0.0193 (1,194) | Â | Â |
39 | 0.0250 | 0.0225 (1,198) | Â | Â |
40 | 0.0792 | 0.0265 (1,321) | < 0.0001 | < 0.0030 |
41 | 0.0167 | 0.0119 (1,089) | Â | Â |
42 | 0.0042 | 0.0040 (1,252) | Â | Â |
44 | 0.3167 | 0.2866 (1,263) | Â | Â |
45 | 0.0083 | 0.0177 (1,241) | Â | Â |
46 | 0.0042 | 0 (19) | Â | Â |
47 | 0.0083 | 0.0039 (513) | Â | Â |
48 | 0.0042 | 0 (909) | Â | Â |
49 | 0.0417 | 0.0171 (1,230) | 0.0153 | Â |
50 | 0.0333 | 0.0140 (1,212) | 0.0414 | Â |
51 | 0.1042 | 0.0696 (1,250) | Â | Â |
52 | 0.0167 | 0.0180 (1,164) | Â | Â |
53 | 0.0083 | 0.0077 (1,163) | Â | Â |
54 | 0 | 0.0058 (1,027 | - - - | Â |
55 | 0.0208 | 0.0259 (1,042) | Â | Â |
56 | 0.0125 | 0.0097 (928) | Â | Â |
57 | 0.0667 | 0.0385 (1,014) | Â | Â |
58 | 0.0042 | 0.0256 (1,014) | 0.0228 | Â |
60 | 0.0583 | 0.1206 (1,086) | Â | Â |
61 | 0.0167 | 0.0173 (980) | Â | Â |
62 | 0.0333 | 0.1285 (1,175) | < 0.0001 | < 0.0030 |
78 | 0.0042 | no data | - - - | Â |